Regulation of B cell responses in lupus and autoimmune diseases
Official title: Regulation of B cell Responses in SLE and Other Autoimmune Diseases
Funded at Emory University · NIH-11332681 · Data updated 2026-11-12
A program funded by NIH to understand how B cells contribute to lupus and related autoimmune diseases, with collaboration through Emory University.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | May 1, 2014 |
| Project end | April 30, 2029 |
| Funding year | 2026 |
| Award (this year) | $78,250 |
| NIH project number | 5U19AI110483-13 |
| Project ID | NIH-11332681 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include individuals with lupus or other autoimmune diseases who may contribute samples or data to related studies.
✕Less likely to help
Patients without autoimmune conditions or those not contributing samples or data may not directly benefit.
What this research studies
This project focuses on how B cells behave in autoimmune conditions like lupus to uncover new ways to support patients. It is run as part of an Autoimmunity Center of Excellence at Emory University, with strong administrative and governance support to ensure productive and ethical research. Researchers will use existing patient data and biological samples under proper safety and regulatory oversight to study B cell biology and disease mechanisms. The work aims to translate findings into better therapies and management strategies for autoimmune diseases.
Why it matters
Potential benefit: If successful, insights could lead to improved treatments that more precisely target B cells involved in autoimmunity.
How similar studies have gone: This area has shown promise in prior autoimmune research, with ongoing advances in understanding B cell roles in disease.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Sanz, Ignacio E. — Emory University
- Study coordinator: Sanz, Ignacio E.
Related research
Other NIH-funded projects on the same topics.
-
Unified and fair multimodal learning for autoimmune diseases
A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.
-
Fair combined medical-data models for autoimmune diseases
A new computer model will learn from medical records, tests, scans, genetics, and wearable data to help spot autoimmune diseases earlier in people with symptoms or at higher risk.
-
Non-immunosuppressive, targeted immune therapies for autoimmune diseases
Aims to develop targeted treatments that selectively remove disease-causing B cells in autoimmune conditions like pemphigus vulgaris without broadly weakening the immune system.
-
Home-based monitoring of environmental exposures and biology for autoimmune diseases
This project develops ways for people with autoimmune conditions to collect environmental and biological data at home so researchers can link exposures to health changes over time.
-
Targeting a specific prolactin receptor form to help people with autoimmune diseases and B-cell cancers
A scientist is testing a new approach that targets a particular prolactin receptor to potentially treat autoimmune diseases and certain B-cell cancers.
-
Understanding B cell Behavior in SLE and Other Autoimmune Diseases
Researchers are studying how B cells and their epigenetic marks behave in people with autoimmune diseases like SLE to find new ways to treat these conditions.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.